MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2024 International Congress

    Progressive freezing of gait in atypical parkinsonism. A Possible Progressive Supranuclear Palsy phenotype.

    H. Pacheco Mendoza, L. Nuñez Orozco, A. Negrete Gomez, J. Delgado Uriarte, C. Gómez Rubio (Mexico, Mexico)

    Objective: Report a case of progressive freezing of gait diagnosed as a Possible Progressive Supranuclear Palsy phenotype Progressive Gait Freezing. Background: PSP is the most…
  • 2024 International Congress

    Impact of Striatal Degeneration on Patient Reported Symptoms in Idiopathic Normal Pressure Hydrocephalus

    Q. Hu, K. Badiola-Lim, D. Karimeddini, C-L. Kuo, N. Prakash (Farmington, USA)

    Objective: To compare the subjective presenting motor (MS) and nonmotor symptoms (NMS) in subjects with idiopathic normal pressure hydrocephalus (iNPH) with and without striatal degeneration…
  • 2024 International Congress

    Initial Results After Launch of Best Practice Advisory for Contraindicated Agents in Parkinson’s Disease and Related disorders

    N. Shah, N. Chunga, K. Amodeo, I. Richard (Rochester, USA)

    Objective: To describe factors associated with triggering a best practice advisory (BPA) for dopamine-blocking agents (DBA) and report preliminary outcomes in hospitalized persons with Parkinson’s…
  • 2024 International Congress

    Genetic Architecture Of Movement Disorder And Its Association With Consanguinity In Pashtoon Population

    SHO. Rehman (Bannu, Kohat, Pakistan)

    Objective: Purpose of the study was to improve the understanding on genetic basis of movement disorders and use of this information for protective measurements like…
  • 2024 International Congress

    Global Trend of Parkinson’s Disease in 38 OECD Countries from 1990-2019: An Insight from the GBD 2019.

    H. Desai, H. Chhayani, N. Brahmbhatt, J. Jobby, B. Desai, M. Lakkimsetti, P. Vemparala (Bhuj, India)

    Objective: The focus of this study was to assess the burden of PD in the organization for economic cooperation and development (OECD) region from 1990-2019.…
  • 2024 International Congress

    Association between Fecal Bile Acids and Levodopa Response in Patients with Parkinson’s Disease

    XD. Yang, Q. Xiao, XQ. He (Shanghai, China)

    Objective: We sought to determine whether fecal bile acids (BAs) could affect levodopa response assessed by levodopa challenge test (LCT) in patients with Parkinson’s disease…
  • 2024 International Congress

    Visual Hallucinations and Pareidolias Across the Lewy Body Disease Spectrum

    S. Kim, B. Jin, S. Lee, KA. Woo, R. Kim, H. Kim, YK. Kim, EJ. Yoon, JY. Lee (Seoul, Republic of Korea)

    Objective: To systemically evaluate visual hallucinations and illusions in patients across the LBD spectrum and to discover the underlying neural mechanism behind these visual symptoms.…
  • 2024 International Congress

    Handwriting Features in Patients with Isolated REM Sleep Behaviour Disorder

    R. Torricelli, J. Kenny, E. Bache, L. Pérez-Carbonell, B. Huxford, H. Chohan, G. Leschziner, A. Lees, A. Schrag, A. Noyce, C. Simonet (London, United Kingdom)

    Objective: To assess iRBD patients’ handwriting features and develop a rating scale capable of detecting early hallmarks of disease. Background: Handwriting changes, such as micrographia,…
  • 2024 International Congress

    A UK-wide Effort for Identification of Loci for Autosomal Dominant Parkinson’s Disease

    R. Tilney, R. Real, S. Jasaityte, Z. Fang, M. Fenn, L. Lange, A. Singleton, C. Blauwendraat, C. Klein, H. Morris, GP2. Genetic Program (London, United Kingdom)

    Objective: (i) To describe the demographic, clinical and genetic features of a large cohort of familial autosomal dominant Parkinson’s disease (PD) patients in the UK.(ii)…
  • 2024 International Congress

    The Inhibition of Mitochondrial NLRP3 Inflammasome Decreases Dopaminergic Cell Death in a 6-OHDA Mouse Model of Parkinson’s Disease.

    E. Dalle, O. Ondoua Nguele, H. Bayaga (Yaounde, Cameroon)

    Objective: To evaluate the possible neuroprotective effects of mitochondrial NLRP3 inflammasome inhibition in a 6-hydroxydopamine mouse model of Parkinson's Disease. Background: Overactivation of brain immune…
  • 1
  • 2
  • 3
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley